 Foster Goss
Concepts (130)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Electronic Health Records | 22 | 2023 | 800 | 3.550 |
Why?
| | Documentation | 9 | 2022 | 167 | 1.900 |
Why?
| | Speech Recognition Software | 4 | 2020 | 11 | 1.840 |
Why?
| | Medical Errors | 3 | 2019 | 85 | 1.680 |
Why?
| | Drug Hypersensitivity | 8 | 2022 | 84 | 1.440 |
Why?
| | Hypersensitivity | 5 | 2022 | 252 | 1.160 |
Why?
| | Vocabulary, Controlled | 4 | 2018 | 41 | 1.160 |
Why?
| | Speech | 2 | 2019 | 68 | 1.120 |
Why?
| | Emergency Service, Hospital | 6 | 2021 | 1820 | 1.020 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 6 | 2022 | 238 | 1.000 |
Why?
| | Natural Language Processing | 5 | 2018 | 72 | 0.860 |
Why?
| | Point-of-Care Systems | 1 | 2021 | 136 | 0.660 |
Why?
| | Drug Prescriptions | 1 | 2021 | 239 | 0.640 |
Why?
| | Medical Records | 1 | 2018 | 153 | 0.580 |
Why?
| | Firearms | 1 | 2022 | 300 | 0.550 |
Why?
| | Uterine Artery Embolization | 1 | 2014 | 6 | 0.480 |
Why?
| | Arteriovenous Malformations | 1 | 2014 | 24 | 0.470 |
Why?
| | Uterine Hemorrhage | 1 | 2014 | 34 | 0.470 |
Why?
| | Health Personnel | 1 | 2019 | 574 | 0.440 |
Why?
| | Uterus | 1 | 2014 | 192 | 0.430 |
Why?
| | Adverse Drug Reaction Reporting Systems | 4 | 2022 | 68 | 0.410 |
Why?
| | Aryl Hydrocarbon Hydroxylases | 1 | 2012 | 41 | 0.390 |
Why?
| | Ticlopidine | 1 | 2012 | 55 | 0.390 |
Why?
| | Thiophenes | 1 | 2012 | 108 | 0.380 |
Why?
| | Angioplasty, Balloon, Coronary | 1 | 2012 | 146 | 0.370 |
Why?
| | Boston | 3 | 2020 | 75 | 0.360 |
Why?
| | Medical Order Entry Systems | 3 | 2015 | 41 | 0.340 |
Why?
| | Piperazines | 1 | 2012 | 309 | 0.340 |
Why?
| | Terminology as Topic | 3 | 2015 | 187 | 0.320 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2012 | 401 | 0.310 |
Why?
| | Systematized Nomenclature of Medicine | 3 | 2018 | 12 | 0.290 |
Why?
| | Humans | 31 | 2023 | 114711 | 0.280 |
Why?
| | Information Storage and Retrieval | 2 | 2021 | 106 | 0.280 |
Why?
| | Decision Support Systems, Clinical | 4 | 2020 | 176 | 0.260 |
Why?
| | Physicians | 3 | 2020 | 772 | 0.260 |
Why?
| | Food Hypersensitivity | 2 | 2017 | 251 | 0.200 |
Why?
| | Workflow | 2 | 2019 | 133 | 0.180 |
Why?
| | Medication Errors | 3 | 2015 | 88 | 0.170 |
Why?
| | Medical Records Systems, Computerized | 2 | 2018 | 88 | 0.170 |
Why?
| | Massive Hepatic Necrosis | 1 | 2019 | 3 | 0.160 |
Why?
| | Biological Ontologies | 1 | 2019 | 14 | 0.160 |
Why?
| | Hepatitis A | 1 | 2019 | 26 | 0.160 |
Why?
| | Speech Perception | 1 | 2020 | 79 | 0.160 |
Why?
| | Allergens | 5 | 2022 | 413 | 0.160 |
Why?
| | Community Health Planning | 1 | 2018 | 43 | 0.160 |
Why?
| | Clinical Audit | 1 | 2018 | 11 | 0.150 |
Why?
| | Travel | 1 | 2019 | 121 | 0.150 |
Why?
| | Datasets as Topic | 1 | 2018 | 100 | 0.150 |
Why?
| | Perception | 1 | 2019 | 310 | 0.140 |
Why?
| | Consensus | 1 | 2019 | 539 | 0.140 |
Why?
| | Linguistics | 1 | 2017 | 26 | 0.140 |
Why?
| | Drug Therapy, Computer-Assisted | 2 | 2015 | 10 | 0.140 |
Why?
| | Female | 12 | 2022 | 59573 | 0.140 |
Why?
| | Models, Theoretical | 2 | 2020 | 515 | 0.130 |
Why?
| | Pharmacovigilance | 1 | 2015 | 14 | 0.130 |
Why?
| | Databases as Topic | 1 | 2015 | 63 | 0.130 |
Why?
| | Ambulatory Care | 1 | 2019 | 478 | 0.130 |
Why?
| | Word Processing | 1 | 2015 | 1 | 0.120 |
Why?
| | Clinical Alarms | 1 | 2015 | 10 | 0.120 |
Why?
| | Data Accuracy | 1 | 2015 | 48 | 0.120 |
Why?
| | Anaphylaxis | 1 | 2017 | 144 | 0.120 |
Why?
| | Physician's Role | 1 | 2016 | 197 | 0.110 |
Why?
| | Male | 10 | 2019 | 55669 | 0.110 |
Why?
| | Attitude of Health Personnel | 1 | 2021 | 975 | 0.110 |
Why?
| | Adult | 5 | 2019 | 30562 | 0.110 |
Why?
| | Social Media | 1 | 2016 | 131 | 0.110 |
Why?
| | Aspirin | 1 | 2016 | 324 | 0.110 |
Why?
| | Middle Aged | 5 | 2019 | 26740 | 0.110 |
Why?
| | Incidence | 2 | 2016 | 2314 | 0.100 |
Why?
| | Diffusion of Innovation | 1 | 2013 | 93 | 0.100 |
Why?
| | Cross-Sectional Studies | 3 | 2018 | 4411 | 0.100 |
Why?
| | Quality Assurance, Health Care | 1 | 2015 | 311 | 0.100 |
Why?
| | Tertiary Care Centers | 1 | 2013 | 126 | 0.100 |
Why?
| | Prasugrel Hydrochloride | 1 | 2012 | 19 | 0.100 |
Why?
| | Aged | 3 | 2019 | 19075 | 0.100 |
Why?
| | Cytochrome P-450 CYP2C19 | 1 | 2012 | 24 | 0.100 |
Why?
| | Microcomputers | 1 | 2012 | 14 | 0.100 |
Why?
| | Sex Factors | 1 | 2017 | 1715 | 0.100 |
Why?
| | Aged, 80 and over | 2 | 2018 | 6346 | 0.090 |
Why?
| | Colorado | 1 | 2018 | 4100 | 0.080 |
Why?
| | Emergency Medicine | 1 | 2012 | 221 | 0.080 |
Why?
| | Analgesics, Opioid | 1 | 2015 | 771 | 0.080 |
Why?
| | Massachusetts | 2 | 2020 | 134 | 0.070 |
Why?
| | Opioid-Related Disorders | 1 | 2015 | 413 | 0.070 |
Why?
| | Surveys and Questionnaires | 1 | 2019 | 4624 | 0.070 |
Why?
| | Patient Care Team | 1 | 2012 | 517 | 0.070 |
Why?
| | Reference Standards | 2 | 2019 | 159 | 0.070 |
Why?
| | Prevalence | 3 | 2018 | 2251 | 0.070 |
Why?
| | Severity of Illness Index | 1 | 2014 | 2540 | 0.070 |
Why?
| | Follow-Up Studies | 1 | 2014 | 4411 | 0.060 |
Why?
| | Risk Assessment | 1 | 2014 | 2968 | 0.060 |
Why?
| | Hypoglycemic Agents | 1 | 2012 | 1012 | 0.060 |
Why?
| | User-Computer Interface | 2 | 2015 | 140 | 0.060 |
Why?
| | United States | 4 | 2019 | 12184 | 0.050 |
Why?
| | Treatment Outcome | 1 | 2014 | 9089 | 0.050 |
Why?
| | Pilot Projects | 2 | 2016 | 1373 | 0.040 |
Why?
| | Peru | 1 | 2019 | 54 | 0.040 |
Why?
| | Hypersensitivity, Delayed | 1 | 2018 | 27 | 0.040 |
Why?
| | Penicillins | 1 | 2018 | 52 | 0.040 |
Why?
| | Fatal Outcome | 1 | 2019 | 284 | 0.040 |
Why?
| | Hypersensitivity, Immediate | 1 | 2018 | 46 | 0.040 |
Why?
| | Radioallergosorbent Test | 1 | 2017 | 3 | 0.040 |
Why?
| | Shellfish | 1 | 2017 | 6 | 0.040 |
Why?
| | Musculoskeletal Pain | 1 | 2016 | 23 | 0.030 |
Why?
| | Data Mining | 1 | 2017 | 100 | 0.030 |
Why?
| | Immunoglobulin E | 1 | 2017 | 314 | 0.030 |
Why?
| | Meaningful Use | 1 | 2015 | 10 | 0.030 |
Why?
| | Delivery of Health Care | 1 | 2022 | 833 | 0.030 |
Why?
| | Exanthema | 1 | 2016 | 74 | 0.030 |
Why?
| | Publishing | 1 | 2017 | 124 | 0.030 |
Why?
| | Utilization Review | 1 | 2015 | 34 | 0.030 |
Why?
| | Socioeconomic Factors | 1 | 2018 | 1079 | 0.030 |
Why?
| | Risk | 1 | 2017 | 812 | 0.030 |
Why?
| | Drug Interactions | 1 | 2015 | 338 | 0.030 |
Why?
| | Language | 1 | 2017 | 263 | 0.030 |
Why?
| | Pharmaceutical Preparations | 1 | 2016 | 165 | 0.030 |
Why?
| | Population Surveillance | 1 | 2016 | 392 | 0.030 |
Why?
| | China | 1 | 2013 | 161 | 0.030 |
Why?
| | Medication Systems, Hospital | 1 | 2012 | 8 | 0.030 |
Why?
| | Retrospective Studies | 2 | 2022 | 12558 | 0.030 |
Why?
| | Clinical Decision-Making | 1 | 2015 | 268 | 0.020 |
Why?
| | Time and Motion Studies | 1 | 2012 | 20 | 0.020 |
Why?
| | Machine Learning | 1 | 2015 | 316 | 0.020 |
Why?
| | Databases, Factual | 1 | 2016 | 1126 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2019 | 2286 | 0.020 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2012 | 228 | 0.020 |
Why?
| | Hospitalization | 1 | 2015 | 1752 | 0.020 |
Why?
| | Risk Factors | 1 | 2015 | 8634 | 0.010 |
Why?
| | Prospective Studies | 1 | 2012 | 6220 | 0.010 |
Why?
| | Adolescent | 1 | 2015 | 17856 | 0.010 |
Why?
|
|
Goss's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|